- Home
- RPTX vs PZC Comparison
RPTX vs PZC Comparison
Compare RPTX & PZC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RPTX
- PZC
- Stock Information
- Founded
- RPTX 2016
- PZC 2002
- Country
- RPTX Canada
- PZC United States
- Employees
- RPTX N/A
- PZC N/A
- Industry
- RPTX Biotechnology: Pharmaceutical Preparations
- PZC Investment Managers
- Sector
- RPTX Health Care
- PZC Finance
- Exchange
- RPTX Nasdaq
- PZC Nasdaq
- Market Cap
- RPTX 155.4M
- PZC 168.0M
- IPO Year
- RPTX 2020
- PZC N/A
- Fundamental
- Price
- RPTX $3.59
- PZC $7.20
- Analyst Decision
- RPTX Strong Buy
- PZC
- Analyst Count
- RPTX 1
- PZC 0
- Target Price
- RPTX $10.00
- PZC N/A
- AVG Volume (30 Days)
- RPTX 71.8K
- PZC 48.2K
- Earning Date
- RPTX 11-07-2024
- PZC 01-01-0001
- Dividend Yield
- RPTX N/A
- PZC 4.68%
- EPS Growth
- RPTX N/A
- PZC N/A
- EPS
- RPTX N/A
- PZC N/A
- Revenue
- RPTX $68,683,000.00
- PZC N/A
- Revenue This Year
- RPTX $16.85
- PZC N/A
- Revenue Next Year
- RPTX N/A
- PZC N/A
- P/E Ratio
- RPTX N/A
- PZC N/A
- Revenue Growth
- RPTX N/A
- PZC N/A
- 52 Week Low
- RPTX $2.71
- PZC $6.30
- 52 Week High
- RPTX $8.49
- PZC $8.20
- Technical
- Relative Strength Index (RSI)
- RPTX 53.00
- PZC 38.25
- Support Level
- RPTX $3.37
- PZC $7.11
- Resistance Level
- RPTX $4.05
- PZC $7.37
- Average True Range (ATR)
- RPTX 0.26
- PZC 0.07
- MACD
- RPTX 0.00
- PZC -0.02
- Stochastic Oscillator
- RPTX 40.65
- PZC 22.97
About RPTX Repare Therapeutics Inc.
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations. The company derives maximum revenue from Canada.
About PZC PIMCO California Municipal Income Fund III of Beneficial Interest
PIMCO CA Muni Income Fund III operates as a closed-end management investment company. The investment objective of the fund is to seek to provide current income exempt from federal and California income tax. Its portfolio of investments includes investment in different sectors such as education, healthcare, industrial and others.